Every day, QIAGEN serves 500,000 customers globally, all seeking insights from DNA and RNA. Delivering Sample to Insight solutions for molecular testing, we help scientists and clinicians achieve breakthroughs in life sciences research, molecular diagnostics and drug development. This is how we make improvements in life possible. In healthcare and academic institutions, and drug-discovery and forensic laboratories, QIAGEN solutions advance disease detection and treatments, enable precision medicine, and aid crime detection and human identification.
Burning Rock Dx specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. With the unique capability and experience in global trials, we seek partnerships to advance the field of companion diagnostics in order to achieve better patient outcomes.
Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by realizing the potential of breath biomarkers for early detection and precision medicine through Breath Biopsy®. Breath Biopsy provides reliable solutions for the collection and analysis of volatile organic compounds (VOCs) produced through metabolic processes or as a result of interaction with external factors such as diet or medication. Changes to exhaled VOCs can be associated with a range of disease conditions and environmental exposures.
Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. With over 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions.
Agilent brings the power of precision medicine to customers, partners, and patients. Agilent is a partner of choice to pharmaceutical and biotech companies producing innovative diagnostics and therapeutics for the benefit of patients around the world.
Larvol provides SaaS solutions that support competitive intelligence and medical communications departments in the pharmaceutical and biotech industry. Our products include biomarker and precision oncology intelligence, secondary competitive intelligence reports, and thought leader tracking. We keep customers at the forefront of clinical and industry developments by curating data from over 25,000 sources into concise reports and tools that provide real-time insights and time-saving analysis. We partner with Fortune 500 companies as well as smaller enterprises.
Proteome Sciences is a CRO specializing in the analysis of proteins detected by Mass Spectrometry. We offer various Discovery and Targeted Services to characterize proteins and their associated post-translational modifications. By using LC-MS2, SysQuant®, and TMTcalibratorTM methodologies we can detect up to 8,000 of proteins/sample. With our proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up- or down-regulated with disease progression or drug treatment.
NeoGenomics is an industry-leading cancer diagnostics and pharma services company. We enable advanced oncology patient care leveraging the most extensive diagnostic solid tumor and hematological test menus, sub-specialized pathology, and expertise in biomarker development. We partner closely with our pharma and research clients to meet program objectives and delivery from biomarker discovery through CDx validation and commercialization.
IDDI provides biostatistical and eClinical services to pharmaceutical and biotech companies since 1991.